Karen Clegg
Signal active
Clinical Operations Director
Contact Information
Social
Primary Organization
CellCentric
Founded
2003
Employees
1-10
Industry
Biotechnology, Medical, Therapeutics
Bio
Karen joined CellCentric in October 2017.
Karen gained her PhD in Biochemistry in 1999 at King's College London. Following clinical operational roles at Parexel International and Napp Pharmaceuticals, Karen joined AstraZeneca where she was Associate Director of Study Management and Global Clinical Trial Leader for a number of first time in man and early phase studies.
More recently Karen was the Clinical Operations Director at Kesios Therapeutics, a biotech company spun-out of Imperial College London focused on multiple myeloma, where she was responsible for all aspects of clinical planning and delivery.
Location
N/A
Board and Advisor Roles
0
N/A
Educations
1
N/A
Profile Resume
Karen Clegg is the Clinical Operations Director at CellCentric. With a background in Biotechnology, Karen Clegg has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity